Group 1 - On February 12, Bibet experienced a decline of 2.02% with a trading volume of 91.04 million yuan [1] - The financing data for Bibet on the same day showed a financing purchase amount of 5.09 million yuan and a financing repayment of 17.15 million yuan, resulting in a net financing outflow of 12.06 million yuan [1] - As of February 12, the total balance of margin trading for Bibet was 134 million yuan, with the financing balance accounting for 6.71% of the circulating market value [1] Group 2 - Bibet's stockholder count reached 13,200 as of January 30, reflecting an increase of 0.81% from the previous period, while the average circulating shares per person decreased by 0.81% to 3,532 shares [1] - For the period from January to September 2025, Bibet reported zero operating revenue and a net loss attributable to shareholders of 107 million yuan [1] - Bibet is located in the Guangzhou High-tech Industrial Development Zone and was established on January 19, 2012, with its listing date set for October 28, 2025, focusing on the independent research and development of innovative drugs [1]
必贝特2月12日获融资买入509.32万元，融资余额1.34亿元